Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Urologic Oncology|December 30, 2008
SUO/SBUR 2007 annual meeting proceedings: overviewChristopher P Evans
Cancer|July 13, 2002
Follow-up surveillance strategies for genitourinary malignanciesChristopher P Evans
The Lancet. Oncology|December 18, 2017
Bipolar androgen therapy: an intriguing paradoxChristopher P Evans
BJU International|June 26, 2004
Evidence-based medicine for the urologistChristopher P Evans
World Journal of Urology|November 13, 2008
Identification of molecular targets in urologic oncologyChristopher P Evans
European Urology|March 27, 2007
Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancerChristopher P Evans
The Journal of Urology|May 11, 2016
Surgery Provides Better Oncologic Outcomes than Radiation for the Treatment of Prostate CancerLaurence Klotz, Christopher P Evans
Investigative and Clinical Urology|June 22, 2016
Autophagy and urothelial carcinoma of the bladder: A reviewThenappan Chandrasekar, Christopher P Evans
European Urology|November 24, 2018
Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 TrialDerya Tilki, Christopher P Evans
The Canadian Journal of Urology|April 30, 2014
The changing landscape of advanced and castration resistant prostate cancer: latest science and revised definitionsDerya Tilki, Christopher P Evans
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Urologic Oncology|December 30, 2008
SUO/SBUR 2007 annual meeting proceedings: overviewChristopher P Evans
Cancer|July 13, 2002
Follow-up surveillance strategies for genitourinary malignanciesChristopher P Evans
The Lancet. Oncology|December 18, 2017
Bipolar androgen therapy: an intriguing paradoxChristopher P Evans
BJU International|June 26, 2004
Evidence-based medicine for the urologistChristopher P Evans
World Journal of Urology|November 13, 2008
Identification of molecular targets in urologic oncologyChristopher P Evans
European Urology|March 27, 2007
Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancerChristopher P Evans
The Journal of Urology|May 11, 2016
Surgery Provides Better Oncologic Outcomes than Radiation for the Treatment of Prostate CancerLaurence Klotz, Christopher P Evans
Investigative and Clinical Urology|June 22, 2016
Autophagy and urothelial carcinoma of the bladder: A reviewThenappan Chandrasekar, Christopher P Evans
European Urology|November 24, 2018
Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 TrialDerya Tilki, Christopher P Evans
The Canadian Journal of Urology|April 30, 2014
The changing landscape of advanced and castration resistant prostate cancer: latest science and revised definitionsDerya Tilki, Christopher P Evans
Pageof 21